|
Proteintech
abin334653 Abin334653, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/abin334653/product/Proteintech Average 93 stars, based on 1 article reviews
abin334653 - by Bioz Stars,
2026-03
93/100 stars
|
Buy from Supplier |
|
Proteintech
tdtomato  Tdtomato, supplied by Proteintech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/tdtomato/product/Proteintech Average 90 stars, based on 1 article reviews
tdtomato - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Antibodies-Online Inc
abin334653  Abin334653, supplied by Antibodies-Online Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/abin334653/product/Antibodies-Online Inc Average 90 stars, based on 1 article reviews
abin334653 - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
|
Proteintech
rfp tdtomato Rfp Tdtomato, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/rfp tdtomato/product/Proteintech Average 96 stars, based on 1 article reviews
rfp tdtomato - by Bioz Stars,
2026-03
96/100 stars
|
Buy from Supplier |
|
Proteintech
rfp Rfp, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/rfp/product/Proteintech Average 93 stars, based on 1 article reviews
rfp - by Bioz Stars,
2026-03
93/100 stars
|
Buy from Supplier |
|
Millipore
mouse anti glutamine synthetase (gs) Mouse Anti Glutamine Synthetase (Gs), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mouse anti glutamine synthetase (gs)/product/Millipore Average 90 stars, based on 1 article reviews
mouse anti glutamine synthetase (gs) - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Cell Research
Article Title: Fibroblasts in an endocardial fibroelastosis disease model mainly originate from mesenchymal derivatives of epicardium
doi: 10.1038/cr.2017.103
Figure Lengend Snippet: Postnatal endocardial and vascular endothelial cells do not contribute to fibroblasts in the EFE-like tissues. (A) Schematic showing experimental strategy. Donor heart from postnatal day (P)7 mouse was implanted into the peritoneal cavity of 8-week-old mouse. Donor hearts were analyzed at day 12 following transplantation. (B) Cartoon showing the heterotopic heart transplant model. The ascending aorta was anastomosed to the infrarenal aorta (Ao), and the pulmonary artery (PA) was anastomosed to the infrarenal vena cava (IVC). (C) Sirius red staining on heart sections shows EFE-like tissues within the inner layer of LV. (D) Schematic figure showing the experimental strategy for lineage tracing of endocardial cells using Npr3-CreER;R26-tdTomato mice. Tamoxifen was administered 2 days before heart transplantation. (E) Immunostaining for tdTomato, PDGFRa and CDH5 on donor heart sections. (F) Immunostaining for tdTomato, FSP1 and CDH5 on donor heart sections shows that endocardial cells do not contribute to FSP1+CDH5− fibroblasts in the EFE-like tissues. Boxed regions are magnified in the right panels. (G) Cartoon showing no lineage conversion from endocardial cells to fibroblasts. (H) Schematic showing the experimental strategy for lineage tracing of vascular endothelial cells using Cdh5-CreER;R26-tdTomato mice. (I) Immunostaining for tdTomato and PDGFRa on donor heart sections. (J) Immunostaining for tdTomato, FSP1 and CDH5 on donor heart sections shows that vascular endothelial cells (ECs) do not contribute to FSP1+CDH5− fibroblasts in the EFE-like tissues. Boxed regions are magnified in the right panels. (K) Cartoon showing no lineage conversion from vascular ECs to fibroblasts. Scale bars, 400 μm in C; 100 μm in E, F, I, J. LV, left ventricle; RV, right ventricle.
Article Snippet: The following first antibodies were used: tdTomato (Rockland, 600-401-379),
Techniques: Transplantation Assay, Staining, Immunostaining
Journal: Cell Research
Article Title: Fibroblasts in an endocardial fibroelastosis disease model mainly originate from mesenchymal derivatives of epicardium
doi: 10.1038/cr.2017.103
Figure Lengend Snippet: Sox9 labels mesenchymal cells at early embryonic stages. (A) Cartoon showing the expression map of Sox9 at E9.5 to E11.5. Blue coloring indicates Sox9+ cells including endocardial cushion mesenchymal cells, proepicardial and epicardial cells. (B) Immunostaining for CDH5 and ESR, where ESR is a surrogate of Sox9, on E9.5 Sox9-CreER embryonic sections shows that ESR/Sox9 is expressed in cushion mesenchymal cells and proepicardial cells, but not in ventricular endocardial cells at E9.5. B1 and B2 are magnified images of boxed regions in B. (C) Immunostaining for ESR and TBX18 shows that ESR is detected in proepicardial cells and epicardial cells at E9.5. White arrowheads indicate ESR+ proepicardial cell and yellow arrowheads indicate ESR+ epicardial cells. (D) Lineage tracing strategy using Sox9-CreER;R26-tdTomato embryos. Tamoxifen was administered at E9.5 and embryos were collected for analysis at E14.5. (E) Immunostaining for tdTomato and PDGFRb on heart sections of E14.5 Sox9-CreER;R26-tdTomato embryos. E1 and E2 are magnified images of boxed regions in E. (F) Immunostaining for tdTomato and PDGFRa on heart sections of Sox9-CreER;R26-tdTomato mice at E14.5 confirms that tdTomato labels epicardial-derived mesenchymal cells. a, atrium; AVC, atrioventricular canal; Epi, epicardium; PE, proepicardium; v, ventricle. Scale bar, 100 μm.
Article Snippet: The following first antibodies were used: tdTomato (Rockland, 600-401-379),
Techniques: Expressing, Immunostaining, Derivative Assay
Journal: Cell Research
Article Title: Fibroblasts in an endocardial fibroelastosis disease model mainly originate from mesenchymal derivatives of epicardium
doi: 10.1038/cr.2017.103
Figure Lengend Snippet: Embryonic cardiac mesenchymal cells (MCs) contribute to the majority of fibroblasts in the EFE-like tissues. (A) Schematic showing strategy for labeling embryonic cardiac MCs using Sox9-CreER;R26-tdTomato mice. Tamoxifen was administered at E9.5 and hearts were collected and transplanted into recipients at P7. The donor hearts were collected for analysis at day 12 following transplantation. (B, C) Immunostaining for tdTomato and PDGFRa shows that tdTomato labels PDGFRa+ fibroblasts (arrowheads) in the EFE-like tissues. Boxed region in B is magnified in C. (D) Quantification of the percentage of tdTomato+PDGFRa+ fibroblasts within the EFE-like tissues (n = 5). (E, F) Representative flow cytometric analysis of the percentage of tdTomato labeled PDGFRa+ cells within the EFE-like hearts. (G) Quantification results of tdTomato labeled PDGFRa+ cells within the EFE-like models by flow cytometric analysis. For each group, n = 4. (H) Immunostaining for tdTomato, CDH5 and FSP1 shows that tdTomato labels FSP1+CDH5− cells (arrowheads) within the EFE-like tissues. Scale bars, 100 μm. LV, left ventricle.
Article Snippet: The following first antibodies were used: tdTomato (Rockland, 600-401-379),
Techniques: Labeling, Transplantation Assay, Immunostaining
Journal: Cell Research
Article Title: Fibroblasts in an endocardial fibroelastosis disease model mainly originate from mesenchymal derivatives of epicardium
doi: 10.1038/cr.2017.103
Figure Lengend Snippet: Nfatc1-2A-CreER-labeled embryonic endocardial cells contribute to fibroblasts in the EFE-like tissues. (A) Schematic showing strategy for lineage tracing of embryonic endocardial cells in an EFE-like model using Nfatc1-2A-CreER;R26-tdTomato mice. (B) Immunostaining for tdTomato and PDGFRa on heart sections shows that a subset of PDGFRa+ fibroblasts was tdTomato+ (arrowheads) in the EFE-like tissues. (C) Quantification of the percentage of tdTomato+PDGFERa+ fibroblasts within the EFE-like tissues. n = 5. (D) Immunostaining for tdTomato and FSP1 on heart sections shows that a subset of FSP1+ cells were tdTomato+ in the EFE-like tissues. Arrowheads indicate tdTomato+FSP1+CDH5− cells. (E, F) Representative flow cytometric analysis of the percentage of tdTomato+ fibroblasts in the EFE-like model. (G) Quantification results of tdTomato-labeled PDGFRa+ cells within the EFE-like model by flow cytometric analysis. For each group, n = 4. (H) Immunostaining for tdTomato, PDGFRa and Ki67 on sections of the EFE-like hearts from Nfatc1-2A-CreER;R26-tdTomato mice. The mice were treated with tamoxifen at E8.5. The donor hearts were transplanted at P7 and collected at day 3 post transplantation. The arrowheads indicate tdTomato+PDGFRa+Ki67+ cells. Scale bars, white, 100 μm; yellow, 25 μm. LV, left ventricle.
Article Snippet: The following first antibodies were used: tdTomato (Rockland, 600-401-379),
Techniques: Labeling, Immunostaining, Transplantation Assay
Journal: Cell Research
Article Title: Fibroblasts in an endocardial fibroelastosis disease model mainly originate from mesenchymal derivatives of epicardium
doi: 10.1038/cr.2017.103
Figure Lengend Snippet: Npr3-CreER-labeled embryonic endocardial cells contribute to fibroblasts within the EFE-like tissues. (A) Schematic showing the strategy for lineage tracing of embryonic endocardial cells in the EFE-like model using Npr3-CreER;R26-tdTomato mice. (B) Immunostaining for tdTomato and PDGFRa on heart sections shows that a subset of PDGFRa+ fibroblasts were tdTomato+ (arrowheads) within the EFE-like tissues. (C) Quantification of the percentage of tdTomato+PDGFRa+ fibroblasts in the EFE-like tissues. n = 5. (D) Immunostaining for tdTomato and FSP1 on heart sections shows that a subset of FSP1+ cells were tdTomato+ within the EFE-like tissues. The arrowheads indicate tdTomato+FSP1+CDH5− cells. (E, F) Representative flow cytometric analysis of the percentage of tdTomato+ fibroblasts in the EFE-like model. (G) Quantification results of tdTomato+ fibroblasts within the EFE-like model by flow cytometric analysis. For each group, n = 4. (H) Immunostaining for tdTomato, PDGFRa and Ki67 on sections of the EFE-like hearts from Npr3-CreER;R26-tdTomato mice. The mice were treated with tamoxifen at E8.5. The donor hearts were transplanted at P7 and collected at day 3 post transplantation. The arrowheads indicate tdTomato+PDGFRa+Ki67+ cells. Scale bars, 100 μm. LV, left ventricle.
Article Snippet: The following first antibodies were used: tdTomato (Rockland, 600-401-379),
Techniques: Labeling, Immunostaining, Transplantation Assay
Journal: Cell Research
Article Title: Fibroblasts in an endocardial fibroelastosis disease model mainly originate from mesenchymal derivatives of epicardium
doi: 10.1038/cr.2017.103
Figure Lengend Snippet: Embryonic epicardial cells contribute to the fibroblasts within the EFE-like tissues. (A) Schematic showing strategy for lineage tracing of embryonic epicardial cells in native hearts using Wt1-CreER;R26-tdTomato mice. (B) Immunostaining for tdTomato and PDGFRa on heart section shows that the majority of PDGFRa+ fibroblasts are tdTomato+. (C) Schematic showing the strategy for lineage tracing of embryonic epicardial cells in the EFE-like model using Wt1-CreER;R26-tdTomato mice. (D) Immunostaining for tdTomato and PDGFRa on heart sections showed PDGFRa+ fibroblasts were tdTomato+ (arrowheads) in the EFE-like tissues. (E, F) Immunostaining for tdTomato and FSP1 on heart sections. Boxed region in E is magnified in F. Yellow arrowheads indicate tdTomato+FSP1+CDH5− cells. (G) Quantification of the percentage of tdTomato+PDGFRa+ fibroblasts. (H, I) Representative flow cytometric analysis of the percentage of tdTomato+PDGFRa+ fibroblasts in the EFE-like model. (J) Quantification results of tdTomato+PDGFRa+/PDGFRa+ within the EFE-like model by flow cytometric analysis. n = 5. (K) Immunostaining for tdTomato, PDGFRa and Ki67 on sections of the EFE-like hearts from Wt1-CreER;R26-tdTomato mice. The mice were administered with tamoxifen at E10.5. The donor hearts were transplanted at P7 and collected at day 3 post transplantation. The arrowheads indicate tdTomato+PDGFRa+Ki67+ cells. (L) Quantification of the percentage of proliferating fibroblasts from different origins. Scale bars, 100 μm. LV, left ventricle; RV, right ventricle.
Article Snippet: The following first antibodies were used: tdTomato (Rockland, 600-401-379),
Techniques: Immunostaining, Transplantation Assay
Journal: Cell Research
Article Title: Fibroblasts in an endocardial fibroelastosis disease model mainly originate from mesenchymal derivatives of epicardium
doi: 10.1038/cr.2017.103
Figure Lengend Snippet: Postnatal epicardial cells do not contribute to the fibroblasts within the EFE-like tissues. (A) Schematic figure showing the strategy for lineage tracing of epicardial cells in native hearts at postnatal stage using Wt1-CreER;R26-tdTomato mice. (B) Immunostaining for tdTomato and PECAM on heart sections shows that postnatal Wt1-CreER labels coronary endothelial cells and epicardial cells. (C) Immunostaining for tdTomato and PDGFRa shows that Wt1-CreER does not label PDGFRa+ fibroblasts at postnatal stage. (D) Schematic figure showing the lineage tracing strategy of postnatal epicardial cells in the EFE-like model using Wt1-CreER;R26-tdTomato mice. (E,F) Immunostaining for tdTomato and PDGFRa on heart sections shows that Wt1-CreER labeled cells (including epicardial cells and some endothelial cells) do not contribute to PDGFRa+ fibroblasts within the EFE-like tissues. Boxed region in E is shown in F. Scale bar, 100 μm. epi, epicardium; LV, left ventricle.
Article Snippet: The following first antibodies were used: tdTomato (Rockland, 600-401-379),
Techniques: Immunostaining, Labeling
Journal: Frontiers in Cellular Neuroscience
Article Title: Development of Neuroregenerative Gene Therapy to Reverse Glial Scar Tissue Back to Neuron-Enriched Tissue
doi: 10.3389/fncel.2020.594170
Figure Lengend Snippet: Primary antibodies used in the study.
Article Snippet: RFP , Rat ,
Techniques: